Decreased parotid salivary cyclic nucleotides related to smell loss severity in patients with taste and smell dysfunction

Metabolism: Clinical and Experimental

Volumn 58, Issue 12, 2009, Pages 1717-1723

  Henkin, Robert Irwin ^a   Velicu, I ^a  

^a Taste and Smell Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; LIPID;

ADULT; AGED; ANOSMIA; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPOSMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; PAROTID GLAND; PRIORITY JOURNAL; RISK ASSESSMENT; SMELLING; SMELLING DISORDER; TASTE ACUITY; TASTE DISORDER;

ADULT; AGED; CYCLIC AMP; CYCLIC GMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; ODORS; OLFACTION DISORDERS; PAROTID GLAND; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SALIVATION; TASTE DISORDERS; YOUNG ADULT;

EID: 71849099141     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.027     Document Type: Article

References (63)

1. Rozenzweig S., Yan W., Dasso M., and Speilman A.I. Possible novel mechanism for bitter taste mediated through cGMP. J Neurophysiol 81 (1999) 1661-1665
2. Kurihara K., and Koyama N. High activity of adenylyl cyclase in olfactory and gustatory organs. Biochem Biophys Res Comm 48 (1972) 30-34
3. Pace U., Hanski E., Salomon Y., and Lancet D. Odorant-sensitive adenylate cyclase may mediate olfactory reception. Nature 316 (1985) 255-258
4. Anholt R.R.H. Molecular neurobiology of olfaction. Crit Rev Neurobiol 7 (1993) 1-22
5. Firestein S., Zufall F., and Shepherd G.M. Single odor-sensitive channels in olfactory receptor neurons are also gated by cyclic nucleotides. J Neurosci 11 (1991) 3565-3572
6. Moon C., Simpson P.J., Cho H., and Ronnett G.Y. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons. J Neurochem 95 (2005) 200-209
7. Henkin R.I., and Velicu I. Aberrant signaling in the olfactory system: a mechanism for smell loss. FASEB J 18 (2004) A1198
8. Henkin R.I., Velicu I., and Papathanassiu A. cAMP and cGMP in human parotid saliva: relationship to taste and smell dysfunction, gender and age. Am J Med Sci 334 (2007) 431-440
9. Henkin R.I. The definition of primary and accessory areas of olfaction as the basis for a classification of decreased olfactory acuity. In: Hayashi T. (Ed). Olfaction and taste II (1967), Pergamon Press, London 235-252
10. Henkin R.I. Concepts of therapy in taste and smell dysfunction: repair of sensory receptor function as primary treatment. In: Kurihara K., Suzuki N., and Ogawa H. (Eds). Olfaction and taste XI (1994), Springer Verlag, New York 568-573
11. Henkin R.I. Taste and smell disorders, human. In: Adelman G., and Smith B.H. (Eds). Encyclopedia of neuroscience. 3rd ed (2004), Birkhauser, Boston
12. Henkin R.I., and Velicu I. cAMP and cGMP in nasal mucus: relationships to taste and smell dysfunction, gender and age. Clin Invest Med 31 (2008) E71-E77
13. Henkin R.I., and Velicu I. cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction. Clin Invest Med 31 (2008) E78-E84
14. Henkin R.I. Evaluation and treatment of human olfactory dysfunction. In: English G.M. (Ed). Otolaryngology vol 2 (1993), Lippincott, Philadelphia 1-86
15. Henkin R.I., Lippoldt R.E., Bilstad J., and Edelhoch H. A zinc protein isolated from human parotid saliva. Proc Natl Acad Sci USA 72 (1975) 488-492
16. R&D Systems. cAMP kit. Minneapolis, MN. Cyclic AMP (low pH) immunoassay. Catalog number DE0355.
17. R&D Systems, Minneapolis, MN. Cyclic GMP (low pH) immunoassay. Catalog number DE0550.
18. Henkin R.I., Schecter P.J., Friedewald W.T., DeMets D.L., and Raff M.S. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 272 (1976) 285-299
19. Stevens S.S. Handbook of psychology (1951), Wiley, New York
20. Henkin R.I., and Hoye R.C. Hyposmia secondary to excision of the olfactory epithelium. The definition of primary and accessory areas of olfaction. Life Sci 5 (1966) 331-334
21. Henkin R.I. Complete anosmia-the absence of olfaction at primary and accessory olfactory areas. Life Sci 3 (1966) 1031-1040
22. Hoye R.C., Ketcham A.S., and Henkin R.I. Hyposmia after paranasal sinus exenteration or laryngectomy. Am J Surg 120 (1970) 485-491
23. Henkin R.I., Hoye R.C., Ketcham A., and Gould W.J. Hyposmia following laryngectomy. Lancet II (1968) 479-487
24. Henkin R.I., and Larson A.L. On the mechanism of hyposmia following laryngectomy in man. Laryngoscope 82 (1972) 836-843
25. Henkin R.I., Velicu I., and Winglee J. Measurement standards of smell acuity are necessary to define pathology and treatment of smell loss. FASEB J 20 (2006) A380
26. Cai D., Qiu J., Cao Z., McAtee M., Bregman B.S., and Filben M.T. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 21 (2001) 4731-4739
27. Kao H.T., Song H.j., Porton B., Ming G.L., Hoh J., Abraham M., et al. A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat Neurosci 8 (2002) 431-437
28. Yankner B.A., and Shooter E.M. The biology and mechanism of action of nerve growth factor. Ann Rev Biochem 51 (1982) 845-868
29. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10 (2004) 610-616
30. Bhatt D.H., Otto S.J., Depoister B., and Fetcho J.R. cAMP-induced repair of zebrafish spinal circuits. Science 305 (2004) 254-258
31. Law J.S., and Henkin R.I. Taste bud adenosine -3′5′ -monophosphate phosphodiesterase: activity, subcellular distribution and kinetic parameters. Res Comm Chem Path Pharm 38 (1982) 439-452
32. Henkin R.I., Law J.S., and Nelson N.R. The role of zinc on the trophic growth factors nerve growth factor and gustin. In: Hurley L.S., Keen C.L., Lonnerdal B., and Rucker R.B. (Eds). Trace elements in man and animals 6 (1988), Plenum Press, New York 385-388
33. Law J.S., and Henkin R.I. Nerve growth factor (NGF) is a Ca-independent activator of Ca-dependent cAMP phosphodiesterase (PDE). Clin Res 33 (1985) 526A
34. Law J.S., and Henkin R.I. Thyroid hormone inhibits purified taste bud membrane adenosine 3′, 5′ -monophosphate phosphodiesterase activity. Res Comm Chem Path Pharm 43 (1984) 449-462
35. Law J.S., and Henkin R.I. Bovine taste bud cyclic adenosine 3′, 5′ monophosphate phosphodiesterase is inhibited by divalent metal ions. Res Commun Chem Pathol Pharmacol 41 (1983) 455-472
36. Reisert J., Bauer P.J., Yau K.W., and Frings S. The Ca-activated Cl channel and its control in rat olfactory receptor neurons. J Gen Physiol 122 (2003) 349-363
37. Nache V., Schulz E., Zimmer T., Kusch J., Biskup C., Koopmann R., et al. Activation of olfactory-type cyclic nucleotide-gated channels is highly cooperative. J Physiol 569 (2005) 91-102
38. Kaupp U.B., and Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev 82 (2002) 769-824
39. Rich T.C., Tse T.E., Rohan J.G., Schaack J., and Karpen J.W. In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors. J Gen Physiol 118 (2001) 63-78
40. Papathanassiu A., and Henkin R.I. cAMP is present in human nasal mucus and may act as a growth factor in cells of the olfactory epithelium. FASEB J 16 (2002) A1153
41. Henkin R.I., and Velicu I. cAMP and cGMP are both present in human nasal mucus and play roles in control of olfactory function. FASEB J 18 (1994) A1198
42. Henkin R.I., Schechter P.J., Hoye R.C., and Mattern C.F.T. Idiopathic hypogeusia with dysgeusia, hyposmia and dysosmia: a new syndrome. J Am Med Assoc 217 (1971) 434-440
43. Henkin R.I., Velicu I., and Papathanassiu A. Dichotomous changes in cAMP and cGMP in human parotid saliva after oral theophylline. FASEB J 17 (2003) A1028
44. Henkin R.I., Velicu I., and Schmidt L. Effective treatment of smell loss with theophylline. FASEB J 22 (2008) B17-976.2
45. Levy L.M., Henkin R.I., Hutter A., Lin C.S., and Schellinger D. Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comput Assist Tomogr 22 (1998) 760-770
46. Velicu I., and Henkin R.I. On the antiapoptotic mechanism of action of theophylline in restoring smell function in patients with hyposmia. J Invest Med 53 (2005) S402
47. Henkin R.I., and Hoetker J.D. Deficient dietary intake of vitamin E in patients with taste and smell dysfunction: is vitamin E a cofactor in taste bud and olfactory epithelium apoptosis and in stem cell maturation and development?. Nutrition 19 (2003) 1013-1021
48. Walerczyk M., and Fabczak S. Additional evidence for the cyclic GMP signaling pathway resulting in the photophobic behavior of Stentor coeruleus. Photochem Photobiol 74 (2001) 829-836
49. Goldberg N.D., and Haddox M.K. Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem 46 (1979) 823-896
50. Walerczyk M., Fabczak H., and Fabszak S. Structure and properties of ion channels activated by cGMP in photoreception cells of vertebrates. Kosmos 47 (1998) 43-52
51. MacFarland R.T. Molecular aspects of cyclic GMP signaling. Zool Sci 12 (1995) 131-163
52. Thompson W.J. Cyclic nucleotide phosphodiesterase: pharmacology, biochemistry and function. Pharmcol Ther 51 (1991) 13-33
53. Firestein B.L., and Bredt D.S. Regulation of sensory neuron precursor proliferation by cyclic GMP-dependent protein kinase. J Neurochem 71 (1998) 1846-1853
54. Shepherd G.M. Sensory transduction: entering the mainstream of membrane signaling. Cell 67 (1991) 845-851
55. Meyer M.R., Angele A., Kremmer E., Kaupp U.B., and Müller F. A cGMP-signaling pathway in a subset of olfactory sensory neurons. Proc Natl Acad Sci USA 97 (2000) 10595-10600
56. Andreeva S.G., Dikkes P., Epstein P.M., and Rosenberg P.A. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci 21 (2001) 9068-9076
57. Kawai F., and Miyachi E. Modulation by cGMP of the voltage-gated currents in newt olfactory receptor cells. Neurosci Res 39 (2001) 327-337
58. Henkin R.I., Doherty A.E., and Martin B.M. Nasal seroproteins: a new frontier in the exploration of physiology and pathology of nasal and sinus disease. In: Veldman J.E., Passali D., and Lim D.J. (Eds). New frontiers in immunobiology in otolaryngology (2000), Kugler, The Hague 127-152
59. Henkin R.I. Report on a survey on smell in the US. Olfactory Rev 1 (1987) 1-8
60. Doty R.L. Clinical studies in olfaction. Chem Senses 30 Suppl 1 (2005) i207-i209
61. Henkin R.I., Velicu I., and Schmidt L. An open label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci 337 (2009) 396-406
62. Fredrickson D.S., and Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 31 (1965) 321-327
63. Fredrickson D.S., and Lees R.S. Familial hyperlipoproteinemia. The metabolic basis of inherited disease. 2nd ed. (1966), McGraw Hill, New York 429-468